open access

Vol 13, No 4 (2018)
Cardiac Surgery
Published online: 2018-09-12
Get Citation

Lymphorrhea in patients with congenital heart defects during cardiac drug therapy or cardiac surgery

Anna Romanowicz, Andrzej Sołtyszewski, Ireneusz Haponiuk, Maciej Chojnicki, Mariusz Steffens, Konrad Paczkowski
DOI: 10.5603/FC.2018.0078
·
Folia Cardiologica 2018;13(4):359-366.

open access

Vol 13, No 4 (2018)
Cardiac Surgery
Published online: 2018-09-12

Abstract

Chylothorax is a rare, but very serious complication of extensive chest surgery (cardiac surgery for congenital heart disease), as well as congenital problem, or consequence of proliferative processes in the chest. We present the causes of chylothorax, diagnostic process, and pharmacological or surgical therapeutic options.

Abstract

Chylothorax is a rare, but very serious complication of extensive chest surgery (cardiac surgery for congenital heart disease), as well as congenital problem, or consequence of proliferative processes in the chest. We present the causes of chylothorax, diagnostic process, and pharmacological or surgical therapeutic options.
Get Citation

Keywords

chylothorax; cardiac surgery; congenital heart disease

About this article
Title

Lymphorrhea in patients with congenital heart defects during cardiac drug therapy or cardiac surgery

Journal

Folia Cardiologica

Issue

Vol 13, No 4 (2018)

Pages

359-366

Published online

2018-09-12

DOI

10.5603/FC.2018.0078

Bibliographic record

Folia Cardiologica 2018;13(4):359-366.

Keywords

chylothorax
cardiac surgery
congenital heart disease

Authors

Anna Romanowicz
Andrzej Sołtyszewski
Ireneusz Haponiuk
Maciej Chojnicki
Mariusz Steffens
Konrad Paczkowski

References (15)
  1. Soto-Martinez M, Massie J. Chylothorax: diagnosis and management in children. Paediatr Respir Rev. 2009; 10(4): 199–207.
  2. Postek G, Werner B, Streuch H, et al. Chylothorax u noworodków. Skuteczne leczenie z zastosowaniem somatostatyny (doniesienie wstępne). Pediatr Pol. 2003; 78: 323–326.
  3. Lopez-Gutierrez JC, Tovar JA. Chylothorax and chylous ascites: management and pitfalls. Semin Pediatr Surg. 2014; 23(5): 298–302.
  4. François M, Caprini A, Hosking B, et al. Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008; 456(7222): 643–647.
  5. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011; 193(4): 607–618.
  6. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005; 438(7070): 946–953.
  7. Widjaja A, Gratz KF, Ockenga J, et al. Octreotide for therapy of chylous ascites in yellow nail syndrome. Gastroenterology. 1999; 116(4): 1017–1018.
  8. Huang Qi, Jiang ZW, Jiang J, et al. Chylous ascites: treated with total parenteral nutrition and somatostatin. World J Gastroenterol. 2004; 10(17): 2588–2591.
  9. Bacewicz L, Stefanowicz M, Markiewicz-Kijewska M, et al. Wybrane powikłania po operacjach w klatce piersiowej u nowordków i niemowląt. Standardy Medyczna Problemy Chirurgii Dziecięcej. 2011; 1(2): 90–97.
  10. Hsu HF, Chou YH, Wang CR, et al. Catheter-related superior vena cava syndrome complicated by chylothorax in a premature infant. Chang Gung Med J. 2003; 26(10): 782–786.
  11. Ibrahim H, Asamoah A, Krouskop RW, et al. Congenital chylothorax in neonatal thyrotoxicosis. J Perinatol. 1999; 19(1): 68–71.
  12. Brito T, Oliveira C, Sousa L, et al. Congenital chylothorax: a case report. Ultrasound Obstet Gynecol. 2003; 21(1): 70–71.
  13. Singh A. Gerbode Defect of Congenital Variety in an Infant: A Case Report. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 2016.
  14. Smoke A, Delegge MH. Chyle leaks: consensus on management? Nutr Clin Pract. 2008; 23(5): 529–532.
  15. Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health. 2008; 44(12): 716–721.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl